Trial Profile
Pilot study of SOM230 for Treatment of Graves' Ophthalmopathy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2019
Price :
$35
*
At a glance
- Drugs Pasireotide (Primary)
- Indications Graves ophthalmopathy
- Focus Therapeutic Use
- Acronyms SOM230
- 07 Sep 2016 New trial record